Document Detail

A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: the PERSEUS Small Vessel trial.
MedLine Citation:
PMID:  21330238     Owner:  NLM     Status:  Publisher    
Aims: Small reference vessel diameter predicts adverse outcomes following coronary stenting. TAXUS Express and TAXUS Liberté paclitaxel-eluting stents (PES) reduce restenosis compared to bare metal stents (BMS) in small diameter vessels. TAXUS Element is a novel thin-strut, platinum chromium stent designed to enhance visibility, conformability, and drug delivery in small diameter vessels. Methods and results: The PERSEUS Small Vessel (SV) prospective, single-arm, superiority trial evaluates the TAXUS Element PES in 224 subjects with target lesion length ≤20 mm and vessel diameter ≥2.25 to <2.75 mm, compared to 125 lesion-matched historical Express BMS control subjects from the TAXUS V trial. The primary endpoint was nine-month in-stent late loss. The secondary endpoint was 12-month target lesion failure (TLF) compared to a pre-specified performance goal (PG). Outcomes were analysed with and without propensity-score adjustment. TAXUS Element was superior to the Express BMS for late loss (0.38±0.51 versus 0.80±0.53 mm respectively; P<0.001), and TLF (7.3%) was significantly less than the 19.5% PG (P<0.001). No differences in mortality, myocardial infarction, or stent thrombosis were observed through 12 months. Results were similar after adjustment. Conclusions: PERSEUS SV supports the efficacy and safety of the platinum chromium, thin-strut TAXUS Element stent in small coronary vessels.
Louis A Cannon; Dean J Kereiakes; Tift Mann; Jeffrey J Popma; Michael R Mooney; Gregory J Mishkel; Tommy C Lee; B Hadley Wilson; Thomas D Stuckey; Steven Orlow; Thomas McGarry; Michael E Ring; Mirle A Kellett; Paul Underwood; Keith D Dawkins
Related Documents :
14508148 - Implantable cardioverter-defibrillators in cardiovascular care: technologic advances an...
25308808 - Atrial tachycardias following atrial fibrillation ablation.
21330238 - A prospective evaluation of the safety and efficacy of taxus element paclitaxel-eluting...
12625608 - Transvenous defibrillation leads: high incidence of failure during long-term follow-up.
2908488 - Viewpoint on the echocardiographic presentations at the american college of cardiology ...
24565698 - Autologous mesenchymal stem cells produce concordant improvements in regional function,...
Publication Detail:
Journal Detail:
Title:  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology     Volume:  6     ISSN:  1969-6213     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-2-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101251040     Medline TA:  EuroIntervention     Country:  -    
Other Details:
Languages:  ENG     Pagination:  920-927     Citation Subset:  -    
Cardiac and Vascular Research Center of Northern Michigan, Northern Michigan Regional Hospital, Petoskey, MI, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Greece Health System Review.
Next Document:  The outcome of bifurcation lesion stenting using a biolimus-eluting stent with a bio-degradable poly...